Examples include chemically modified N-desulfated, N-acetylated and glycol-split heparin derivatives [189] and a heparanase inhibitor [190], that alone or together with lapatinib, resulted in inhibition of the tumor growth in patients with myeloma [186] or in brain metastatic breast cancer, respectively [191]. The gene discussed is HPSE; the disease is neoplasm.